BioNTech SE (BNTX) Total Current Liabilities (2018 - 2025)

BioNTech SE has disclosed Total Current Liabilities across 8 years of filings, most recently posting $2.5 billion for Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $2.5 billion, down 7.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.5 billion (down 7.51% YoY), and the FY2025 annual result was $2.4 billion, down 10.23% from the prior year.
• Total Current Liabilities came in at $2.5 billion for Q4 2025 at BioNTech SE, down from $2.6 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $5.8 billion in Q3 2021 to a low of $1.6 billion in Q1 2021.
• The 5-year median for Total Current Liabilities is $2.6 billion (2025), against an average of $2.9 billion.
• Across the five-year window, Total Current Liabilities jumped 1743.58% in 2021 and tumbled 61.52% in 2023, its largest moves.
• BioNTech SE's Total Current Liabilities stood at $4.0 billion in 2021, then decreased by 24.42% to $3.0 billion in 2022, then dropped by 26.0% to $2.2 billion in 2023, then climbed by 21.03% to $2.7 billion in 2024, then declined by 7.51% to $2.5 billion in 2025.
• The last three Total Current Liabilities figures came in at $2.5 billion (Q4 2025), $2.6 billion (Q3 2025), and $2.1 billion (Q2 2025), per Business Quant data.